Compare ZYME & CNOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZYME | CNOB |
|---|---|---|
| Founded | 2003 | 1982 |
| Country | United States | United States |
| Employees | N/A | 756 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2022 | N/A |
| Metric | ZYME | CNOB |
|---|---|---|
| Price | $26.11 | $32.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $38.90 | $31.25 |
| AVG Volume (30 Days) | ★ 625.3K | 519.0K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.48% |
| EPS Growth | ★ 33.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $105,965,000.00 | N/A |
| Revenue This Year | $183.10 | $42.85 |
| Revenue Next Year | N/A | $7.27 |
| P/E Ratio | ★ N/A | $17.02 |
| Revenue Growth | ★ 38.87 | N/A |
| 52 Week Low | $11.86 | $22.07 |
| 52 Week High | $29.75 | $33.97 |
| Indicator | ZYME | CNOB |
|---|---|---|
| Relative Strength Index (RSI) | 63.53 | 56.42 |
| Support Level | $22.44 | $31.52 |
| Resistance Level | $26.75 | N/A |
| Average True Range (ATR) | 1.11 | 0.84 |
| MACD | 0.40 | -0.07 |
| Stochastic Oscillator | 84.13 | 47.74 |
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets, and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental, and consumer wages.